ServiceSource International (NASDAQ:SREV) Stock Moves in a Range: Now What?

The customer journey experience company ServiceSource International (NASDAQ:SREV) has not been in the news in recent times and that is possibly the reason why the company’s stock has been moving in a range as well. The last important development about the company was the announcement of its financial results for the quarter that ended on June 30, 2021. The announcement was made back on July 28. Gary B. Moore, who…

Read More >>

McEwen Mining Inc (NYSE:MUX) Stock Attempts To Bounce Back: What Next?

McEwen Mining Inc (NYSE:MUX) is among the notable laggards in the market over the course of the past week and has declined by as much as 11% during the period. There has been no news about the company this week but earlier on this month McEwen reported its financial results for the fiscal second quarter and for the first half of the year, both of which ended on June 30,…

Read More >>

NGL Energy Partners LP (NYSE:NGL) Stock Sees Continues Sell_Off: But Why?

Earlier on in the week NGL Energy Partners LP (NYSE:NGL) announced its financial results for the first fiscal quarter of 2022 but the results did not seem to have a positive effect on the stock. Over the course of the past week the NGL Energy Partners suffered from a steady selloff and declined by as much as 8.50%. In this context, it is necessary for investors to perhaps take a…

Read More >>

Washington Prime Group Inc (NYSE:WPG) Stock Falls 33% in a Month: Here is Why

Over the course of the past month, investors have been involved in a steady selloff in the Washington Prime Group Inc (NYSE:WPG) stock and during that period the stock has gone down by as much as 33%. Considering the scale of the decline it is important for investors to figure out if the fall could actually be an opportunity to get into the stock. Earlier on in the week the…

Read More >>

Eros STX Global Corp (NYSE:ESGC) Stock Extends Slump: Falls 50% in a Week

Eros STX Global Corp (NYSE:ESGC) has had a pretty hard time in the capital markets in recent weeks and the patter continued on Wednesday as investors continued to engage in a selloff in the company’s stock. The Eros STX stock decline by as much as 20% yesterday due to the selloff and that took the cumulative decline over the course of the past month to as much as 50%. However,…

Read More >>

LightInTheBox Holding Co Ltd (NYSE:LITB) Stock Rockets 40%: What’s The Buzz?

The stock market can sometimes be a bit confusing for investors since sometimes stocks may make moves that may seem a bit irrational. One of the stocks that made such a move yesterday was the LightInTheBox Holding Co Ltd (NYSE:LITB) stock. There was no news about the company at all but investors piled on to the stock in a big way nonetheless and the LightInTheBox stock ended the day with…

Read More >>

EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) Stock Falls 22% in a Week: A Good Opportunity?

In recent days, there have been many stocks which have recorded considerable losses and one of those is the EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) stock. Over the course of the past week, the stock has been in the middle of a steady selloff and has actually gone down by as much as 22%. On Wednesday, the company was in the news against owing to a key announcement and it may be…

Read More >>

Adma Biologics Inc (NASDAQ:ADMA) Stock Gains After Earnings: How to Trade Now?

One of the stocks that could be on the radars of many investors today is the Adma Biologics Inc (NASDAQ:ADMA) stock. Yesterday, the company announced its financial results for the second fiscal quarter on Wednesday and since then the stock has been in focus. It has made an upward move in the premarket trading period and already gone up by as much as 4%. Although it remains to be seen…

Read More >>

Zosano Pharma Corporation (NASDAQ:ZSAN) Stock Corrects 11% in a Month: A Good Opportunity?

Zosano Pharma Corporation (NASDAQ:ZSAN) is down 11% in a month. The company reported its Q2 financial results and business highlights for the period ending June 30, 2021.  CEO Steven Lo said they are delighted to have commenced the healthy volunteer’s pharmacokinetic study requested by the US FDA for NDA resubmission for M207.  Lo said that the study evaluated safety and pharmacokinetics in 38 healthy volunteers. The company is working to…

Read More >>
x